CN106668241A - External preparation of paederia scandens extract for treating haemorrhoids - Google Patents

External preparation of paederia scandens extract for treating haemorrhoids Download PDF

Info

Publication number
CN106668241A
CN106668241A CN201710173482.4A CN201710173482A CN106668241A CN 106668241 A CN106668241 A CN 106668241A CN 201710173482 A CN201710173482 A CN 201710173482A CN 106668241 A CN106668241 A CN 106668241A
Authority
CN
China
Prior art keywords
external preparation
extract
fevervine
group
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710173482.4A
Other languages
Chinese (zh)
Inventor
李仲昆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201710173482.4A priority Critical patent/CN106668241A/en
Publication of CN106668241A publication Critical patent/CN106668241A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Alternative & Traditional Medicine (AREA)

Abstract

The invention provides an external preparation of a paederia scandens extract for treating haemorrhoids. When the weight ratio of the paederia scandens extract in the external preparation is 10-90%, the external preparation has an obvious therapeutical effect for haemorrhoids; when the weight ratio of the paederia scandens extract in the external preparation is 20-70%, the therapeutical effect for haemorrhoids is stronger. Compared with the prior art, the external preparation of the paederia scandens extract for treating haemorrhoids is simple in preparation, reliable in curative effect and low in cost, and does not have toxicity or side effects, therefore, the external preparation has a very high application value and is suitable for popularization and application.

Description

A kind of fevervine extract external preparation for treating hemorrhoid
Technical field
The present invention relates to a kind of fevervine extract external preparation for treating hemorrhoid, for treating hemorrhoid.
Background technology
Hemorrhoid are a kind of commonly encountered diseases, frequently-occurring disease, and main clinical manifestation is to have blood in stool, pain, edema, falling inflation, prurituss, secretions The symptom such as increase and deviate from, had a strong impact on life, working and learning, so exploitation has the hemorrhoid treating medicine of good result Thing is significant.
At present the method for the treatment of hemorrhoid mainly has Drug therapy, surgical ligation and injection treatment.Anorectal educational circles of China is clear and definite Point out that the purpose treated is not to eliminate hemorrhoid body, but eliminate symptom.These treatment concepts make non-operative treatment especially basic medicine The importance of thing treatment is burst.It is to eliminate symptom, asymptomatic hemorrhoid that the suggestion of present scholar mostly is the therapeutic purposes of hemorrhoid Without the need for treatment, Symptomatic hemorrhoid more than 90% can Jing non-operative treatment eliminate symptom, only less than 10% hemorrhoid patients need Surgical intervention.Drug therapy energy reducing swelling and alleviating pain, relief of symptoms, turn avoid the pain of operation and the complication of injection treatment, So vast majority of people is adapted to adopt Drug therapy.Drug therapy occupies critical role in the treatment of hemorrhoid, Chinese medicine preparation by In evident in efficacy and low toxicity side effect, extensively by expert and the favorable comment of patient.The Chinese medicine preparation of hemorrhoid is treated on market ointment, bolt Agent, patch, ointment, lotion, oral formulations etc., manufacturer is also numerous.That what is sold on domestic market mainly has Ma Yinglong Moschus ZHICHUAN SHUAN, cream, Gangtai Ointment, hemorrhoid-eliminating paste, jiuhua plaster, bear's gall ointment etc..There is heat-clearing and toxic substances removing, detumescence these medicines more The effects such as pain relieving, removing the necrotic tissue and promoting granulation, but still can improve in anti-inflammatory analgesic effect.
The content of the invention
It is an object of the invention to provide a kind of fevervine extract external preparation of energy effectively treatment hemorrhoid.
A kind of preparation method of the fevervine extract external preparation for treating hemorrhoid, comprises the following steps:
(1)Prepare wash clean and dried fevervine powder 1000g, in being put into decoction kettle, add deionized water, big fire to decoct 30min, then 2h is cooked by slow fire, decocting liquid is filtered, filtrate is collected, dense fluids is concentrated into, add ethanol to reach concentration of alcohol 80%, stand overnight, drying precipitate is collected, obtain 100g extracts.Except containing paederoside, Paederosidie Acid first in extract Outside fat, also containing other effective ingredient, including flavonoid, iridoidses, sterols, triterpeness etc., such as kaempferol and Cortex querci dentatae Element and its glycoside, asperuloside etc., work, therefore curative effect is good compared with single component.
(2)Extract is prepared into into suppository or ointment, wherein when the ratio of the weight containing extract is 10-90%, containing fevervine Glycosides is 0.78-7.02%, and Paederosidie Acid formicester is 0.77-6.93%;With containing extract weight ratio as 20-70% preferably.
The present invention provides the fevervine extract external preparation for the treatment of hemorrhoid, has the effect that compared with prior art: The present invention is prepared simply, and curative effect reliability has no toxic side effect, and with low cost, therefore, the present invention has very high using value, It is suitable to popularization and application.
Specific embodiment
Embodiment one
Fat-soluble suppository substrate, it is 10-90% to add fevervine extract to make weight ratio, is poured into after heating and melting in mould, is cooled down Take out.It is 0.78-7.02% to contain paederoside in through determining suppository, and Paederosidie Acid formicester is 0.77-6.93%.
Embodiment two
Fat-soluble suppository substrate, it is 20-70% to add fevervine extract to make weight ratio, is poured into after heating and melting in mould, is cooled down Take out.It is 1.56-5.46% to contain paederoside in through determining suppository, and Paederosidie Acid formicester is 1.54-5.39%.
Embodiment three
Emulsifiable paste matrix, it is 10-90% to add fevervine extract to make weight ratio, after mix homogeneously.Contain in through determining emulsifiable paste Paederoside is 0.78-7.02%, and Paederosidie Acid formicester is 0.77-6.93%.
Example IV
Emulsifiable paste matrix, it is 20-70% to add fevervine extract to make weight ratio, after mix homogeneously.Contain in through determining emulsifiable paste Paederoside is 1.56-5.46%, and Paederosidie Acid formicester is 1.54-5.39%.
The mice dimethylbenzene antiinflammatory of embodiment five is tested
48 KM mices, male and female half and half, 20 ± 2g of body weight is randomly divided into 4 groups, i.e. model control group, fevervine and extracts by body weight Thing group (concentration is 20% emulsifiable paste, and dosage is 100mg/), MAYINGLONGZHICHUANGGAO group (dosage is 100mg/), fevervine Glycosides group(Emulsifiable paste containing paederoside 20%, dosage is 100mg/)12 per group.
Experimental technique:The μ l of dimethylbenzene 20 are taken, each mouse right ear is applied to.Take after 30min each by reagent be uniformly applied to respectively it is little Mus auris dextra, auris dextra is put to death to after dimethylbenzene 3.5h, and determines the ear method of double differences, and assay method is:Two ears are cut at auricle baseline, is used 8mm card punch lays auricle at the same position of left and right ear, weighs, the ear method of double differences=auris dextra piece weight-left auricle weight.
As a result fevervine extract has obvious antiinflammatory action, and antiphlogistic effects are better than MAYINGLONGZHICHUANGGAO group, paederoside group. The ear method of double differences of model group is 6.92 ± 1.26, and the ear method of double differences of fevervine extract group is 3.89 ± 1.56, MAYINGLONGZHICHUANGGAO group The ear method of double differences is 4.77 ± 1.18, and the paederoside group ear method of double differences is 5.97 ± 1.44.
The mice analgesic activity of embodiment six is tested
KM mices 48, male and female half and half, 20 ± 2g of body weight is randomly divided into 4 groups, i.e. model control group, fevervine and extracts by body weight Thing group (concentration is 20% emulsifiable paste, and dosage is 100mg/), MAYINGLONGZHICHUANGGAO group (dosage is 100mg/), fevervine Glycosides group(Emulsifiable paste containing paederoside 20%, dosage is 100mg/)12 per group.
Experimental technique:Mice anum administration, with 10mg cotton balls 100mg medicines are stained with, and cotton balls filled in into internal rectum, and daily one Secondary, continuous three days, 30 minutes after last time administration is finished, rectal wall injected 5% formalin at anus 3.5cm 0.2ml.Writhing number of times in record mice 20 minutes.As a result fevervine extract has obvious analgesic effect, and analgesic effect is better than horse Should imperial ZHICHUANG GAO group, paederoside group.The writhing number of times of model group is 46.8 ± 11.3, the writhing number of times of fevervine extract group For 28.9 ± 16.5, MAYINGLONGZHICHUANGGAO group writhing number of times is 35.7 ± 17.4, paederoside group writhing number of times is 41.8 ± 16.3。
The experiment of the rat Oleum Tiglii hemorrhoid model of embodiment seven
48 SD rats (200 ± 20g) are randomly divided into 4 groups, i.e. model control group, fevervine extract group by body weight, and (concentration is 20% emulsifiable paste, dosage is 200mg/), MAYINGLONGZHICHUANGGAO group (dosage is 200mg/), paederoside group(Containing chicken arrow The emulsifiable paste of rattan glycosides 20%, dosage is 200mg/)12 per group.Administration:Rat carries a few days ago drop rectum with drug, secondary daily, 200mg medicines are stained with cotton balls, cotton balls is filled in into internal rectum, during administration next time, should first check whether internal rectum has cotton balls (if any cotton Ball should take out).Last time administration should be 2 hours after modeling.
Modeling:Oleum Tiglii is a kind of conventional proinflammatory agent, conventional Oleum Tiglii mixed liquor with 1 part of distilled water, 4 parts of pyridines, 5 Part ether and 10 part of 15% Oleum Tiglii diethyl ether solution are prepared.Oleum Tiglii mixed liquor is stained with 10mg cotton balls, by the cotton balls after immersion Rat anal is put into, is taken out after stopping 15 seconds.
Index determining:After modeling 7 hours, every rat intravenous injection 1% her Wen orchid normal saline solution (2ml/kg), Sacrificed by exsanguination animal after 40 minutes, cut-off intestinal and perianal tissue, use acetone normal saline 7 after weighing:3 solution soaking 48 are little When, 3000rpm is centrifuged 10 minutes, takes supernatant and surveys absorbance in 590nm, as evaluation vascular permeability index,
As a result show, fevervine extract can well reduce the rectum vein permeability of Oleum Tiglii hemorrhoid model mice, curative effect Better than MAYINGLONGZHICHUANGGAO group, paederoside group.The light absorption value of model group is 0.161 ± 0.026, the suction of fevervine extract group Light value is 0.111 ± 0.036, and the light absorption value of MAYINGLONGZHICHUANGGAO group is 0.127 ± 0.041, and paederoside group light absorption value is 0.141±0.031。

Claims (3)

1. a kind of fevervine extract external preparation for treating hemorrhoid, it is characterised in that the weight of fevervine extract in preparation Containing paederoside it is 0.78-7.02% in preparation than for 10-90%, Paederosidie Acid formicester is 0.77-6.93%, is contained in extract There are flavonoid, iridoidses, sterols, triterpeness etc., such as kaempferol, Quercetin and its glycoside, asperuloside, fevervine Glycosides, Paederosidie Acid formicester etc., work, therefore curative effect is good compared with single component.
2. fevervine extract external preparation as claimed in claim 1, it is characterised in that the weight of fevervine extract in preparation It is 1.56-5.46% that amount contains paederoside than being 20-70%, in preparation, and Paederosidie Acid formicester is 1.54-5.39%.
3. the extract external preparation of the fevervine according to described in any of the above-described claim prepares the medicine for the treatment of hemorrhoid.
CN201710173482.4A 2017-03-22 2017-03-22 External preparation of paederia scandens extract for treating haemorrhoids Pending CN106668241A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710173482.4A CN106668241A (en) 2017-03-22 2017-03-22 External preparation of paederia scandens extract for treating haemorrhoids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710173482.4A CN106668241A (en) 2017-03-22 2017-03-22 External preparation of paederia scandens extract for treating haemorrhoids

Publications (1)

Publication Number Publication Date
CN106668241A true CN106668241A (en) 2017-05-17

Family

ID=58826229

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710173482.4A Pending CN106668241A (en) 2017-03-22 2017-03-22 External preparation of paederia scandens extract for treating haemorrhoids

Country Status (1)

Country Link
CN (1) CN106668241A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200044373A (en) * 2018-10-19 2020-04-29 호서대학교 산학협력단 Composition for skin regeneration and wound healing containing absolute of paederia foetida flower

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102846784A (en) * 2011-06-23 2013-01-02 宁波大昌药业有限公司 Paederia scandens water extract, and preparation method and application thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102846784A (en) * 2011-06-23 2013-01-02 宁波大昌药业有限公司 Paederia scandens water extract, and preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
田华咏等: "《土家医方药精选》", 31 January 2014, 中医古籍出版社 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200044373A (en) * 2018-10-19 2020-04-29 호서대학교 산학협력단 Composition for skin regeneration and wound healing containing absolute of paederia foetida flower
KR102127570B1 (en) 2018-10-19 2020-06-26 호서대학교 산학협력단 Composition for skin regeneration and wound healing containing absolute of paederia foetida flower

Similar Documents

Publication Publication Date Title
CN103272041B (en) A kind of Chinese medicine composition for the treatment of hemorrhoid
CN102772712B (en) Traditional Chinese medicine composition for treating heat-toxicity, flourishing and blood stasis type diabetic foot
CN106668241A (en) External preparation of paederia scandens extract for treating haemorrhoids
CN103432497B (en) External preparation for treating haemorrhoids
CN103479970B (en) External medicine for treating rheumatic arthralgia
CN102824570B (en) Method of preparing traditional Chinese medicine lotion for treating dark urine type closed fracture
CN104758726A (en) Traditional Chinese medicine composition for treating urinary tract infection
CN104208295A (en) Medicine for treating scalds
CN103908600A (en) Externally-applied medicine for treating rheumatoid arthritis damp-heat blockage symptom as well as preparation method and administration method thereof
CN107468857A (en) A kind of Chinese medicinal preparation method that can treat gastric ulcer
CN102824563B (en) Method for preparing Chinese medicinal lotion for treating closed fracture due to frequent micturition and urgent micturition
CN102727641B (en) External traditional Chinese medicine for treating superficial phlebitis
CN105616536A (en) Traditional Chinese medicine liniment for treating leukoderma
CN110339281A (en) A kind of Chinese medicine hemostatic formulations and preparation method thereof
CN103768290A (en) Traditional Chinese medicine composition for treating synovitis and preparation method thereof
CN102824546B (en) Method for preparing traditional Chinese medicinal lotion for treating closed fracture due to deficiency of kidney yin
CN107812091A (en) A kind of Chinese medicine preparation for treating phlebitis caused by chemotherapeutics and preparation method thereof
CN105963469A (en) Traditional Chinese herbal medicine composition for treating haemorrhoids and postoperative complications thereof
CN103110737B (en) Traditional Chinese medicine composition for treating gynecologic inflammation and preparation method thereof
CN102579777A (en) Preparation method of Chinese medicinal lotion for treating chronic ulcer of shank with itching syndrome
CN102614357A (en) Preparation method of traditional Chinese medicine lotion for treating lumbago type lumbago
CN103751272B (en) Treat the Chinese medicine composition and its extract of ankylosing spondylitis
CN101390973A (en) Use of traditional Chinese medicine in preparing medicine for treating retinal vein obstruction
CN107551030B (en) A kind of Chinese medicine composition, preparation and the preparation method of anti-venous thronbosis
CN106389702A (en) Traditional Chinese medicine for recovering symptoms of gynecological and obstetric surgery and preparation method of traditional Chinese medicine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170517

WD01 Invention patent application deemed withdrawn after publication